| Document Date: 2010-04-29 14:51:54
Open Document File Size: 2,09 MBShare Result on Facebook
City Rochester / / Company S. Karger AG / Mayo Medical Laboratories / Ford / Surgical Management / IgG / / Continent America / Europe / / Country Switzerland / United States / / Currency MOP / / / Event FDA Phase / / Facility Mayo Clinic’s Hyperoxaluria Center Mayo Clinic / Mayo Clinic / Health/National Institute of Diabetes / / IndustryTerm consensus algorithm / investigational protocols / enzyme systems / end product / Diagnostic algorithm / treatment services / temporary solution / / MedicalCondition Urologic Diseases / kidney stone / associated renal injury / Primary Hyperoxaluria / primary hyperoxaluria type II / primary hyperoxaluria type I. FEBS Lett / AGT enzyme deficiency / oxalate cardiomyopathy / I primary hyperoxaluria / urinary tract infection / chronic renal failure / Nausea / Human Swayback / idiopathic stone disease / secondary inflammatory response cause renal damage / fatigue / Primary hyperoxaluria type I. Review / Interest Copper Deficiency Myelopathy / primary hyperoxaluria dietary modification / developed kidney failure / glyoxylate aminotransferase deficiency / subacute combined degeneration / Plasma Testing Primary hyperoxaluria / nephrocalcinosis / eyes Anemia Skin ulcers Cardiac arrhythmias / tiredness / primary hyperoxalurias / MS / renal injury / Copper Deficiency Myelopathy / primary hyperoxaluria I / Symptomatic Kidney Stones Large kidney stones / prominent sensory ataxia / end-stage renal failure / primary hyperoxaluria type / Swayback / vitamin B12 deficiency / Oxalosis Introduction Kidney stones / copper deficiency / active calcium oxalate stone disease / disease / spastic gait / idiopathic hyperoxaluria / Unclassified Hyperoxaluria / I primary hyperoxaluria probands / myelopathy presenting / acquired copper deficiency / urolithiasis / Kidney Diseases / severe systemic disease / neutropenia / marked hyperoxaluria and clinical features / μmol/L Hyperoxaluria / neurological manifestations / hyperoxaluria / renal failure Renal failure / pain / oxalate injury / kidney failure / renal insufficiency / both enteric and primary hyperoxaluria / hyperoxaluria including betaine / Primary Hyperoxaluria PHI / autosomal recessive disorders / deficiency / AGT deficiency / renal failure / marked hyperoxaluria / High Fluid Intake Hyperoxaluria / each patient’s disease / anemia / Enteric hyperoxaluria / neurological syndrome / / MedicalTreatment Kidney transplantation / lithotripsy / surgery / Kidney transplant / liver transplantation / dialysis / / MusicGroup Nausea / / Organization Health/National Institute of Diabetes & Digestive / GRHPR / Oxalosis and Hyperoxaluria Foundation / / Person Neeraj Kumar / Van Acker / / / Position Ferree PM / designer / home physician / / Product Beta-2 / Mayo Clinic Hyperoxaluria / / ProvinceOrState Minnesota / / Technology research protocol / Antibodies / transplantation / genotyping / evidence-based algorithm / consensus algorithm / gas chromatography / Genotype / dialysis / / URL www.mayoreferenceservices.org/communique / www.ohf.org / www.mayoclinic.org/nephrology-rst / /
SocialTag |
I M P R O V I N G PAT I E N T C A R E T H R O U G H E S O T E R I C L A B O R AT O RY T E S T I N G APRIL 2007 Laboratory and Molecular Diagnosis of Primary Hyperoxaluria and Oxalosis